Docosahexaenoic acid decreases TNF-α-induced lectin-like oxidized low-density lipoprotein receptor-1 expression in THP-1 cells

Schrijvers, 2007, Phagocytosis in atherosclerosis: molecular mechanisms and implications for plaque progression and stability, Cardiovasc. Res., 73, 470, 10.1016/j.cardiores.2006.09.005 Lu, 2013, Psychological stress, vascular inflammation, and atherogenesis: potential roles of circulating cytokines, J. Cardiovasc Pharmacol., 62, 6, 10.1097/FJC.0b013e3182858fac Hotamisligil, 1995, Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance, J. Clin. Invest., 95, 2409, 10.1172/JCI117936 Olefsky, 2010, Macrophages, inflammation, and insulin resistance, Annu. Rev. Physiol., 72, 219, 10.1146/annurev-physiol-021909-135846 Fazio, 2001, The inflamed plaque: cytokine production and cellular cholesterol balance in the vessel wall, Am. J. Cardiol., 88, 12E, 10.1016/S0002-9149(01)01717-9 Gerbod-Giannone, 2006, TNFα induces ABCA1 through NF-B in macrophages and in phagocytes ingesting apoptotic cells, Proc. Natl. Acad. Sci. USA, 103, 3112, 10.1073/pnas.0510345103 Skjphit-Arkil, 2012, Tumor necrosis factor-α and receptor activator of nuclear factor-κB ligand augment human macrophage foam-cell destruction of extracellular matrix through protease-mediated processes, Assay Drug Dev. Technol., 10, 69, 10.1089/adt.2010.0366 Sawamura, 1997, An endothelial receptor for oxidized low-density lipoprotein, Nature, 386, 73, 10.1038/386073a0 Chen, 2002, LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis, Pharmacol. Ther., 95, 89, 10.1016/S0163-7258(02)00236-X Kume, 2001, Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in atherogenesis, Trends Cardiovasc. Med., 11, 22, 10.1016/S1050-1738(01)00079-2 Cominacini, 2000, Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species, J. Biol. Chem., 275, 12633, 10.1074/jbc.275.17.12633 Hofnagel, 2004, Proinflammatory cytokines regulate LOX-1 expression in vascular smooth muscle cells, Arterioscler. Thromb. Vasc. Biol., 24, 1789, 10.1161/01.ATV.0000140061.89096.2b Li, 2000, Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors, Arterioscler. Thromb. Vasc. Biol., 20, 1116, 10.1161/01.ATV.20.4.1116 Morawietz, 1999, Angiotensin II induces LOX-1, the human endothelial receptor for oxidized low-density lipoprotein, Circulation, 100, 899, 10.1161/01.CIR.100.9.899 Murase, 1998, Fluid shear stress transcriptionally induces lectin-like oxidized LDL receptor-1 in vascular endothelial cells, Circ. Res., 83, 328, 10.1161/01.RES.83.3.328 Reiss, 2009, Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) in atherogenesis: a brief review, Curr. Med. Chem., 16, 2641, 10.2174/092986709788681994 Ogura, 2009, Lox-1: the multifunctional receptor underlying cardiovascular dysfunction, Circ. J., 73, 1993, 10.1253/circj.CJ-09-0587 Kataoka, 1999, Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions, Circulation, 99, 3110, 10.1161/01.CIR.99.24.3110 Xu, 2012, LOX-1 in atherosclerosis: biological functions and pharmacological modifiers, Cell Mol. Life Sci., 70, 2859, 10.1007/s00018-012-1194-z Uchida, 2011, Associations of atherosclerotic risk factors with oxidized low-density lipoprotein evaluated by LOX-1 ligand activity in healthy men, Clin. Chim. Acta, 412, 1643, 10.1016/j.cca.2011.05.022 Li, 2000, Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB, Circulation, 102, 1970, 10.1161/01.CIR.102.16.1970 Li, 1999, Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation, Circ. Res., 84, 1043, 10.1161/01.RES.84.9.1043 Zhou, 2004, Inhibition of oxidative stress and improvement of endothelial function by amlodipine in angiotensin II-infused rats, Am. J. Hypertens., 17, 167, 10.1016/j.amjhyper.2003.09.007 Moriwaki, 1998, Expression of lectin-like oxidized low density lipoprotein receptor-1 in human and murine macrophages: upregulated expression by TNF-alpha, FEBS Lett., 440, 29, 10.1016/S0014-5793(98)01414-8 Lee, 2008, A combination of Lox-1 and Nox1 regulates TLR9-mediated foam cell formation, Cell Signal, 20, 2266, 10.1016/j.cellsig.2008.08.022 Holub, 2009, Docosahexaenoic acid (DHA) and cardiovascular disease risk factors, Prostaglandins Leukot. Essent. Fatty Acids, 81, 199, 10.1016/j.plefa.2009.05.016 Chen, 2003, EPA and DHA attenuate ox-LDL-induced expression of adhesion molecules in human coronary artery endothelial cells via protein kinase B pathway, J. Mol. Cell Cardiol., 35, 769, 10.1016/S0022-2828(03)00120-2 Wang, 2011, Docosahexaenoic acid attenuates VCAM-1 expression and NF-κB activation in TNF-α-treated human aortic endothelial cells, J. Nutr. Biochem., 22, 187, 10.1016/j.jnutbio.2010.01.007 Balakumar, 2012, Fish oil and vascular endothelial protection: bench to bedside, Free Radic. Biol. Med., 53, 271, 10.1016/j.freeradbiomed.2012.05.005 Oliver, 2012, Docosahexaenoic acid attenuates macrophage-induced inflammation and improves insulin sensitivity in adipocytes-specific differential effects between LC n-3 PUFA, J. Nutr. Biochem., 23, 1192, 10.1016/j.jnutbio.2011.06.014 Krieger, 1993, Molecular flypaper, host defense, and atherosclerosis, J. Biol. Chem., 268, 4569, 10.1016/S0021-9258(18)53430-X Yamagata, 2013, Dietary β-carotene regulates interleukin-1β-induced expression of apolipoprotein E in astrocytes isolated from stroke-prone spontaneously hypertensive rats, Neurochem. Int., 62, 43, 10.1016/j.neuint.2012.11.001 Yehuda, 2011, Human atherosclerotic plaque lipid extract promotes expression of proinflammatory factors in human monocytes and macrophage-like cells, Atherosclerosis, 218, 339, 10.1016/j.atherosclerosis.2011.07.120 Koo, 2013, Mycophenolic acid regulates spleen tyrosine kinase to repress tumour necrosis factor-alpha-induced monocyte chemotatic protein-1 production in cultured human aortic endothelial cells, Cell Biol. Int., 37, 19, 10.1002/cbin.10003 Cawood, 2010, Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability, Atherosclerosis, 212, 252, 10.1016/j.atherosclerosis.2010.05.022 Basuroy, 2009, Nox4 NADPH oxidase mediates oxidative stress and apoptosis caused by TNF-alpha in cerebral vascular endothelial cells, Am. J. Physiol. Cell Physiol., 296, C422, 10.1152/ajpcell.00381.2008 Hashizume, 2012, Atherogenic effects of TNF-α and IL-6 via up-regulation of scavenger receptors, Cytokine, 58, 424, 10.1016/j.cyto.2012.02.010 Richard, 2009, Docosahexaenoic acid down-regulates endothelial Nox 4 through a sPLA2 signalling pathway, Biochem. Biophys. Res. Commun., 389, 516, 10.1016/j.bbrc.2009.09.013 McLaren, 2011, Eicosapentaenoic acid and docosahexaenoic acid regulate modified LDL uptake and macropinocytosis in human macrophages, Lipids, 46, 1053, 10.1007/s11745-011-3598-1 Mullen, 2010, Anti-inflammatory effects of EPA and DHA are dependent upon time and dose-response elements associated with LPS stimulation in THP-1-derived macrophages, J. Nutr. Biochem., 21, 444, 10.1016/j.jnutbio.2009.02.008 Yang, 2013, Docosahexaenoic acid inhibition of inflammation is partially via cross-talk between Nrf2/heme oxygenase 1 and IKK/NF-κB pathways, J. Nutr. Biochem., 24, 204, 10.1016/j.jnutbio.2012.05.003